Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Resveratrol helps prevent finasteride-induced damage in male rats, improving reproductive function.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

Hair loss in men is mainly caused by hormones and genes, and while current treatments can slow it down, they can't fully stop it.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Women with PCOS have higher oxidative stress and hormone imbalances, suggesting managing oxidative stress could help.

Spexin levels are lower in PCOS patients and linked to metabolic and hormonal issues.

Certain gene variations are linked to a higher risk of severe acne, suggesting a genetic influence on the condition.

The case shows skin changes can indicate deeper health issues like insulin resistance, which are challenging to manage.

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Ethosomes are a promising way to deliver drugs through the skin.

Postmenopausal virilization can be caused by ovarian hyperthecosis, treatable with surgery.

Certain drugs can cause male infertility, so fertility counseling and sperm preservation are advised.

Lower DHT and higher testosterone levels increase brain activation but don't change behavior in heavy drinkers.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

Testosterone pellets may help women's sexual function but have safety concerns and need more research.

Prostaglandin D2 increases testosterone levels in skin cells through reactive oxygen species, not enzymes, which could lead to new hair loss treatments.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Finasteride reduces hair growth and is safe for women with excessive hair.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.